PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSareum Regulatory News (SAR)

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 31.00
Bid: 30.00
Ask: 32.00
Change: -3.00 (-8.82%)
Spread: 2.00 (6.667%)
Open: 34.00
High: 34.00
Low: 31.00
Prev. Close: 34.00
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 8 - Sareum Holdings plc

7 Mar 2005 12:01

Sareum Holdings PLC07 March 2005 Date of Disclosure 7 March 2005 DISCLOSURE UNDER RULES 8.1(a), 8.1(b)(i) AND 8.3 OF THE CITY CODE ON TAKEOVERSAND MERGERS Date of dealing 4 March 2005 Dealing in SAREUM HOLDINGS PLC (1) Class of securities (eg ordinary shares) Ordinary Shares (2) Amount sold Price per unit Peter Hoskins 250,000 2.75p (3) Resultant total of the same class owned or controlled (and percentage ofclass) Resultant holding for party named above: 7,700,050 (2.21%) (4) Party making disclosure Peter Hoskins (5) EITHER (a) Name of vendor (Note 1) Peter Hoskins OR (b) If dealing fordiscretionary client(s), name of fund management organisation (6) Reason for disclosure (Note 2) (a) associate of (i) offeror (Note 3) No (ii) offeree company NoSpecify which category or categories of associate (1-8 overleaf)If category (8), explain. (b) Rule 8.3 (ie disclosure because of ownership or control of 1% or more of theclass of relevant securities dealt in) YES Signed, for and on behalf of the party named in (4) above N/A (Also print name of signatory) Peter Hoskins Telephone and extension number 01799 530084______________________________________ Note 1. Specify owner, not nominee or vehicle company. If relevant, alsoidentify controller of owner, eg where an owner normally acts on instructions ofa controller. Note 2. Disclosure might be made for more than one reason; if so, state allreasons. Note 3. Specify which offeror if there is more than one. Note 4. When an arrangement exists with any offeror, with the offeree companyor with an associate of any offeror or of the offeree company in relation torelevantsecurities, details of such arrangement must be disclosed, as required by Note 6on Rule 8. Note 5. It may be necessary, particularly when disclosing derivativetransactions, to append a sheet to this disclosure form so that all relevantinformation can be given. Note 6. In the case of an average price bargain, each underlying trade should bedisclosed. Note 7. The resultant total percentage holding of the class of relevant securityis to be calculated by reference to the percentage held and in issue outsidetreasury. For full details of disclosure requirements, see Rule 8 of the Code. If indoubt, contact the Panel on Takeovers and Mergers, Monitoring Section, Tel. No:020 7638 0129. E-mail: monitoring@disclosure.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
31st Aug 20067:01 amRNSCancer Drug Collaboration
15th Aug 20067:01 amRNSCollaboration with Lundbeck
13th Jul 20067:01 amRNSExtension of Collaboration
20th Jun 20067:03 amRNSCollaboration with Sirtris
14th Jun 20069:45 amRNSHolding(s) in Company
8th Jun 20067:00 amRNSSuccess with Schering AG
28th Mar 20065:38 pmRNSHolding(s) in Company
8th Mar 20061:08 pmRNSHolding(s) in Company
23rd Feb 20067:01 amRNSInterim Results
16th Feb 200612:30 pmRNSExercise of option
16th Feb 200610:51 amRNSNotice of Results
13th Feb 20064:26 pmRNSExercise of option
9th Feb 20067:01 amRNSUSD5m Idenix Collaboration
26th Jan 20067:01 amRNSCollaboration with UCB
19th Jan 20067:00 amRNSH.Lundbeck A/S Collaboration
17th Jan 20067:00 amRNSCollaboration with Organon
12th Jan 20067:02 amRNSBcl-2 added to Crystal Bank
10th Jan 20067:00 amRNSCollaborative Agreement
13th Dec 20057:02 amRNSCollaborative Agreement
24th Nov 20057:01 amRNSCrystal Bank Developments
9th Nov 20058:48 amRNSHolding(s) in Company
7th Nov 200511:02 amRNSResult of AGM
27th Oct 20057:00 amRNSCollaboration with Schering
10th Oct 200512:59 pmRNSAnnual Report and Accounts
22nd Sep 20057:00 amRNSCancer Therapy Deal
19th Sep 20057:00 amRNSPreliminary Results
1st Sep 20057:02 amRNSLaunch of Crystal Bank
10th Aug 20057:00 amRNSDeal with Spanish Pharma
1st Aug 20059:30 amRNSHolding(s) in Company
29th Jul 20053:32 pmRNSHolding(s) in Company
25th Jul 20057:00 amRNSMajor Drug Collaboration
30th Jun 20057:00 amRNSSuccess Milestone
13th May 20057:01 amRNSFirst UK Installation
25th Apr 200512:59 pmRNSOffer discussions terminated
11th Apr 20057:00 amRNSContract Extension
29th Mar 20057:00 amRNSInterim Results
7th Mar 200512:01 pmRNSRule 8 - Sareum Holdings plc
7th Mar 20057:01 amRNSRule 2.10 Announcement
4th Mar 20057:00 amRNSStatement re speculation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.